Benztropine Mesylate Tablets USP 2mg Manufacturer, Exporter, and Supplier in India
Benztropine Mesylate Tablets USP 2mg, manufactured by Aetos Pharma, is an effective medication for managing Parkinson’s disease and drug-induced movement disorders (extrapyramidal symptoms). It belongs to the anticholinergic class of drugs, helping restore neurotransmitter balance in the brain, thereby reducing muscle stiffness, tremors, and involuntary movements.
Key Benefits:
- Helps control Parkinson’s disease symptoms like muscle rigidity and tremors.
- Reduces involuntary movements caused by certain medications, particularly antipsychotics.
- Enhances mobility and overall motor function.
Aetos Pharma is Benztropine Mesylate Tablets USP 2mg Manufacturer in India and also Exporters in the Latin American region including countries such as Bolivia, Ecuador, Dominican Republic, Chile, Venezuela, Brazil, Colombia, Mexico, Guyana, Guatemala, Panama, Trinidad and Tobago, and El Salvador.
Aetos Pharma Private Limited is a leading WHO-GMP EU-GMP Pharmaceuticals Manufacturer exports products to the following continents
Angola | Benin | Botswana | Burkina Faso | Burundi | Cameroon | Cape Verde | Central African Republic | Chad (Tchad) | Comoros | Republic of the Congo | Democratic Republic of the Congo | Côte d’Ivoire (Ivory Coast) | Djibouti | Equatorial Guinea | Egypt (Misr) | Eritrea | Ethiopia (Abyssinia) | Gabon | The Gambia | Ghana | Guinea | Guinea-Bissau | Kenya | Lesotho | Liberia | Libya | Madagascar | Malawi | Algeria | Mali | Mauritania | Mauritius | Morocco (Al Maghrib) | Mozambique | Namibia | Niger | Nigeria | Rwanda | São Tomé and Príncipe | Senegal | Seychelles | Sierra Leone | Somalia | South Africa | South Sudan | Sudan | Swaziland (Eswatini) | Tanzania | Togo | Tunisia | Uganda | Western Sahara | Zambia | Zimbabwe
Afghanistan | Armenia | Azerbaijan | Bahrain | Bangladesh | Bhutan | Brunei | Cambodia (Kampuchea) | Georgia | India | Indonesia | Iran | Iraq | Japan | Jordan (Al Urdun) | Kazakhstan | Kuwait | Kyrgyzstan | Laos | Lebanon (Lubnan) | Malaysia | Maldives | Mongolia | Myanmar (Burma) | Nepal | North Korea | Oman | Philippines | Qatar | Russia | Saudi Arabia | Singapore | South Korea | Sri Lanka | Syria | Tajikistan | Thailand | Turkey | Turkmenistan| Taiwan | United Arab Emirates | Uzbekistan | Vietnam | Yemen
Albania | Andorra | Austria | Belarus | Belgium | Bosnia and Herzegovina | Bulgaria | Croatia | Cyprus | Czech Republic | Denmark | Estonia | Finland | Georgia | Germany | Greece | Hungary | Iceland | Republic of Ireland | Italy | Kosovo | Latvia | Liechtenstein | Lithuania | Luxembourg | North Macedonia | Malta | Moldova | Monaco | Montenegro | Netherlands | Norway | Poland | Portugal | Romania | San Marino | Serbia | Slovakia | Slovenia | France | Spain | Sweden | Switzerland | Ukraine | United Kingdom
Canada | United States of America | Navassa Island | Puerto Rico | US Virgin Islands | Guam | American Samoa
Brazil | Argentina | Bolivia | Chile | Colombia | Ecuador | Falkland Islands | French Guiana | Guyana | Paraguay | Peru | South Georgia and the South Sandwich Islands | Suriname | Uruguay | Venezuela | Belize | Costa Rica | El Salvador | Guatemala | Honduras | Nicaragua | Panama | Haiti | Antigua and Barbuda | Bahamas | Barbados | Cuba | Dominica | Grenada | Jamaica | Saint Lucia | Saint Kitts and Nevis | Saint Vincent and the Grenadines | Trinidad and Tobago
Australia | Fiji | New Zealand | Federated States of Micronesia | Kiribati | Marshall Islands | Nauru | Palau | Papua New Guinea | Samoa | Solomon Islands | Tonga | Tuvalu | Vanuatu